Research Studies

Current Clinical Trials:

Study: Acne

Purpose: To evaluate the safety and efficacy of the investigational Cutera® 1726 nm laser system (also referred to as ‘Alice’) for the treatment of mild to severe acne vulgaris. Subjects will receive three 1726 nm laser treatments at 3 week intervals. Follow-up visits will occur at approximately 10 days post each treatment (via phone) and at 4-, 12-, 26- and 52-weeks post-final treatment.

Qualifications:

• Female and male subjects, ages 16 to 60 years
• Fitzpatrick skin types I-IV with mild, moderate, or severe acne vulgaris

Duration: Approx. 18 months

Location: Hackensack, NJ

Compensation: $325

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Vitiligo Trial

Purpose: Vitiligo is a skin condition in which there is a loss of color (referred to as “depigmentation”) from areas of skin. This results in uneven white patches that have no pigment, but the skin feels like normal. The purpose of the study you are being asked to participate in is to evaluate the safety and effectiveness of the RECELL® Device when used for repigmentation of stable vitiligo. Stable vitiligo means that the areas affected by loss of pigment have been unchanged for at least the last 12 months. The study will evaluate the effect of using RECELL for repigmentation.

Qualifications:

• Male and Females, 18 years or older
• Diagnosed with Focal, segmental or generalized (i.e., nonsegmental) vitiligo photographically documented as stable (No new lesions within the previous 12 months)

Duration: Approx. 52 weeks

Location: Hackensack, NJ

Compensation: If all visits kept, up to $1350 will be paid to patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Alopecia Areata

Purpose: This research study will look at two different doses of CTP-543 compared to placebo (looks like the study drug, but does not contain active ingredients) when given to research subjects with alopecia areata (sudden hair loss) twice-daily for 24 weeks. The main purpose is to determine if CTP-543 will result in hair regrowth, and to see if taking CTP-543 is safe.

Qualifications:

• Male and Females, ages 18 to 65 inclusive
• Definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months and not exceeding 10 years at the time of Screening. Total disease duration greater than 10 years is permitted.
• At least 50% scalp hair loss, as defined by a SALT score ≥50, at Screening and Baseline.

Duration: Approx. 28 weeks

Location: Hackensack, NJ

Compensation: If all visits kept, up to $500 will be paid to patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Atopic dermatitis

Purpose: A clinical research study to test the effectiveness of an investigational medication to reduce symptoms. This study will also include 2 vaccines commonly used in adults with moderate-to-severe AD. The main purpose of this study is to learn whether an investigational drug could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD.

Qualifications:

• Male and Females, ages 18 to 55 years of age
• Have moderate to severe atopic dermatitis for at least 1 year
• Failure to improve with topical prescriptions

Duration: 32 weeks/ visiting doctors office 7 to 11 times

Location: Hackensack, NJ

Compensation: If all visits are kept, up to $600 will be paid to the patient *once all visits are completed*

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Treatment to Lift Lax Skin

Purpose: To evaluate the safety and efficacy of Sofwave treatment to lift lax tissue in the submental and neck zones and to lift the eyebrow. This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or submental or “off the face” (abdomen, or arms, or thighs, or Décolleté) treatments (per PI discretion, 2-12 weeks apart) using the Sofwave System. Follow up visits will be conducted at 3 and 6 months post final treatment.

Qualifications:

• Healthy female and male subjects between the ages 35-80.
• Non-Smoker.
• Fitzpatrick skin type I-VI.
• Desire to lift lax skin in the neck and submental and/or to lift the brows.

Duration: Approx. 6-8 months

Location: Hackensack, NJ

Compensation: $160 for study visits

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Microneedling

Purpose: A clinical research study to test the effectiveness of the Collagen P.I.N. microneedling device in improving the appearance of moderate to severe non-facial scars. Subjects of will be required to complete four (4) treatment visits and one (1) follow-up visit.

Qualifications:

• Adults 22 years of age or older
• At least 1 non-facial trauma or surgical scar present for at least 6 months

Duration: Approx. 22 weeks

Location: Hackensack, NJ

Compensation: $250

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Photo Study: Port-Wine Stain

Purpose: This is a one-time photo study to document different forms of port-wine stain (PWS). Patients would come into our Hackensack location to verify eligibility then go to the sponsors Parsippany location for the photo session.

Qualifications:

• Adults 18 – 65 years old
• Clinical diagnosis of port wine stain (PWS) located on the face and/or neck
• Fitzpatrick skin type I-VI

Duration: Approx. 1 hour

Location: Hackensack/Parsippany, NJ

Compensation: $100

To participate contact Diana Aranzazu, [email protected], 609-219-5621

---

Study: Prurigo Nodularis

Purpose: To evaluate the effect of NAL ER (oral tablet) on itch as assessed by the percentage of Responders (‘response’ is defined as a ≥ 4-point reduction in the 7-day average Worst Itch – Numerical Rating Scale [WI-NRS]).

Qualifications:

• Male and Females, 18 years or older
• Clinical diagnosis of Prurigo Nodularis (PN)

Duration: Up to 52 weeks

Location: Hackensack, NJ

Compensation: TBD

To participate contact Diana Aranzazu, [email protected], 609-219-5621